ZA908933B - Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones - Google Patents

Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones

Info

Publication number
ZA908933B
ZA908933B ZA908933A ZA908933A ZA908933B ZA 908933 B ZA908933 B ZA 908933B ZA 908933 A ZA908933 A ZA 908933A ZA 908933 A ZA908933 A ZA 908933A ZA 908933 B ZA908933 B ZA 908933B
Authority
ZA
South Africa
Prior art keywords
enveloped virus
quinolyloxazole
ones
glycoprotein
prevention
Prior art date
Application number
ZA908933A
Other languages
English (en)
Inventor
Sai Prasad Sunkara
Prasad Sunkara Sai
Winton Dennis Jones
Dennis Jones Winton
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA908933B publication Critical patent/ZA908933B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA908933A 1989-11-13 1990-11-07 Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones ZA908933B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43531889A 1989-11-13 1989-11-13

Publications (1)

Publication Number Publication Date
ZA908933B true ZA908933B (en) 1991-08-28

Family

ID=23727911

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908933A ZA908933B (en) 1989-11-13 1990-11-07 Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones

Country Status (11)

Country Link
EP (1) EP0428105B1 (de)
JP (1) JP2927930B2 (de)
KR (1) KR0162639B1 (de)
AT (1) ATE100318T1 (de)
AU (1) AU630249B2 (de)
DE (1) DE69006187T2 (de)
DK (1) DK0428105T3 (de)
ES (1) ES2062266T3 (de)
IE (1) IE63851B1 (de)
PH (1) PH27309A (de)
ZA (1) ZA908933B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Also Published As

Publication number Publication date
JP2927930B2 (ja) 1999-07-28
DK0428105T3 (da) 1994-02-28
IE63851B1 (en) 1995-06-14
IE904079A1 (en) 1991-05-22
KR910009260A (ko) 1991-06-28
ATE100318T1 (de) 1994-02-15
KR0162639B1 (ko) 1998-12-01
PH27309A (en) 1993-05-28
EP0428105B1 (de) 1994-01-19
JPH03173886A (ja) 1991-07-29
AU6592990A (en) 1991-05-16
ES2062266T3 (es) 1994-12-16
DE69006187D1 (de) 1994-03-03
EP0428105A2 (de) 1991-05-22
DE69006187T2 (de) 1994-05-05
AU630249B2 (en) 1992-10-22
EP0428105A3 (en) 1991-12-11

Similar Documents

Publication Publication Date Title
SG52628A1 (en) Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
EA200201279A1 (ru) Способы и композиции для лечения вирусного гепатита c
EA199901031A1 (ru) Производные бензимидазола
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
MX9805441A (es) Compuestos terapeuticos.
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
EP0594795A4 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren.
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
PH27309A (en) Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
UA37251C2 (uk) Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
DE69231465T2 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
CA2155129A1 (en) Combinations of Retroviral Inhibitors
RU93055680A (ru) Ингибиторы вич-протеазы, способ получения, их использование, композиция
RU93055683A (ru) Ингибиторы вич-протеазы, способ их получения, их использование, композиция
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections